Amgen Faces Class Action Lawsuit for Allegedly Hiding $10.7B Tax Bill From Investors

Amgen’s motion for dismissal was denied after a New York judge agreed the company did not sufficiently disclose to shareholders back taxes and penalties owed to the Internal Revenue Service.

Scroll to Top